Evidence map›Paper›PMID 42183235›Full record

ArticleFrontiers in immunology2026

The immune dysregulation landscape and dynamic regulation of competing endogenous RNAs in spinal cord injury.

Yuxuan Yao, Wenliang Guo, Xingyun Cai, Yuchang Gui, Jingzhi Yao, Yuting Lu, Yuxin Liang, Wenshu Wang, Zhibiao Tan, Jinxiang Zhang and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuxuan Yao *Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Wenliang Guo *Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xingyun Cai *Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yuchang GuiDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jingzhi YaoDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yuting LuDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yuxin LiangGuangxi Medical University, Nanning, Guangxi, China.
Wenshu WangGuangxi Medical University, Nanning, Guangxi, China.
Zhibiao TanDepartment of Rehabilitation Medicine, Guigang City People's Hospital, Guigang, Guangxi, China.
Jinxiang ZhangDepartment of Joint Surgery and Geriatric Orthopedics, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Jianwen XuDepartment of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Spinal cord injury (SCI) triggers a complex secondary injury cascade that critically limits neural repair. Although microRNAs have been implicated in post-SCI inflammation and neural regeneration, the key competing endogenous RNA (ceRNA) network regulating immune dysregulation remains unclear. Methods: Peripheral blood miRNA data from six SCI patients and six healthy controls were combined with peripheral blood mRNA expression profiles from the GEO dataset (GSE151371) to identify differentially expressed miRNAs and mRNAs. Characteristic miRNAs were screened using LASSO and SVM-RFE machine learning algorithms, with core miRNAs subsequently validated via receiver operating characteristic (ROC) analysis. Their target mRNAs were predicted and validated, enabling the construction of a ceRNA regulatory network. Concurrent immune infiltration analysis was performed. WGCNA was applied to the core mRNAs to define immune-related co-expression modules and conduct functional enrichment. Furthermore, SCI samples were classified into two molecular subtypes with distinct immune microenvironments. Finally, RT-qPCR was used to quantify the expression of core miRNAs in validation cohorts, and functional experiments (CCK-8 and Transwell assays) were performed in C8-D1A astrocytes to assess the roles of selected miRNAs in cell proliferation and migration. Results: Six differentially expressed miRNAs were identified in SCI patients: four upregulated (hsa-miR-3680-5p, hsa-miR-410-3p, hsa-miR-6883-3p, hsa-miR-4508) and two downregulated (hsa-miR-3685, hsa-miR-6798-3p). ROC analysis verified the robust diagnostic value of these core miRNAs, with AUC > 0.85. RT-qPCR validation confirmed these expression patterns in the blood of SCI patients, consistent with bioinformatics predictions, p < 0.05. Their common targets (KLHL3, PRKCH, BACH2, MAP2K6, SIPA1L2) showed opposite expression patterns. WGCNA revealed immune-related modules enriched in T/B cell receptor and MAPK signaling pathways. Immune infiltration analysis indicated increased neutrophils and monocytes, with decreased lymphocytes. Notably, functional assays demonstrated that miR-3680-5p, miR-6798-3p, and miR-6883-3p did not directly affect astrocyte proliferation but significantly modulated astrocyte migration when co-cultured with macrophages, suggesting their involvement in astrocyte-macrophage crosstalk during SCI repair. Conclusion: We constructed an immune-related ceRNA network in SCI, identifying six core miRNAs that regulate immune pathways and astrocyte-macrophage interactions. These findings provide new insights into SCI pathogenesis and potential therapeutic targets.

Indexed as

Gene Expression RegulationMicroRNAsRNA, Competitive EndogenousSpinal Cord InjuriesAnimalsAstrocytesCell MovementCell ProliferationComputational BiologyFemaleGene Expression ProfilingGene Regulatory NetworksHumansMaleRNA, MessengerMicroRNAsRNA, Competitive EndogenousRNA, MessengerceRNAimmune infiltrationmiRNAmolecular subtypesspinal cord injury

Identifiers

PMID42183235
PMCPMC13189784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.